4.6 Review

Susceptibility-Guided Therapy vs. Bismuth-Containing Quadruple Therapy as the First-Line Treatment for Helicobacter pylori Infection: A Systematic Review and Meta-Analysis

Related references

Note: Only part of the references are listed.
Article Infectious Diseases

Comparison of tailored Helicobacter pylori eradication versus modified bismuth quadruple therapy in Korea: a randomized controlled trial

Jun-Hyung Cho et al.

Summary: The study compared the success rate, adverse drug events, and cost-effectiveness of tailored Helicobacter pylori eradication and modified bismuth-containing quadruple therapy, finding that PAM-B therapy showed similar efficacy and improved cost-effectiveness compared to tailored therapy based on the results of DPO-PCR tests.

EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2022)

Article Gastroenterology & Hepatology

Chinese Consensus Report on Family-Based Helicobacter pylori Infection Control and Management (2021 Edition)

Song-Ze Ding et al.

Summary: Experts discussed and modified 23 original statements on family-based H. pylori infection transmission, control and management, and reached consensus on 16 statements. The final report consists of three parts: H. pylori infection and transmission among family members, prevention and management of H. pylori infection in children and elderly people within households, and strategies for prevention and management of H. pylori infection for family members. In addition to the 'test-and-treat' and 'screen-and-treat' strategies, this consensus also introduced a novel third 'family-based H. pylori infection control and management' strategy to prevent its intrafamilial transmission and development of related diseases.
Review Gastroenterology & Hepatology

AGA Clinical Practice Update on the Management of Refractory Helicobacter pylori Infection: Expert Review

Shailja C. Shah et al.

Summary: The purpose of this CPU Expert Review is to provide clinicians with guidance on the management of Helicobacter pylori after initial eradication therapy failure. The review is not formal systematic, but based on literature to provide practical advice. The strength or quality of the evidence was not formally rated, instead a combination of available evidence and consensus-based expert opinion were used to develop best practice advice.

GASTROENTEROLOGY (2021)

Article Gastroenterology & Hepatology

Application of WeChat platform in the management of patients infected with Helicobacter pylori

Huan Ma et al.

Summary: The use of WeChat platform for managing patients with H. pylori infection showed better medication adherence, regular follow-up, and eradication rate compared to traditional management methods, resulting in statistically significant differences between the two groups.

HELICOBACTER (2021)

Review Gastroenterology & Hepatology

Susceptibility-guided versus empirical treatment for Helicobacter pylori infection: A systematic review and meta-analysis

Rachel Gingold-Belfer et al.

Summary: The study suggests that susceptibility-guided treatment may be slightly superior to empirical first-line triple therapy for previously untreated Helicobacter pylori infection. However, susceptibility-guided treatment does not appear to be superior to empirical first-line quadruple therapy or empirical rescue therapy.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

Genotype profiles ofHelicobacter pylorifrom gastric biopsies and strains with antimicrobial-induced resistance

You-hua Wang et al.

THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2020)

Review Gastroenterology & Hepatology

Review of current diagnostic methods and advances in Helicobacter pylori diagnostics in the era of next generation sequencing

Daniel Pohl et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2019)

Article Public, Environmental & Occupational Health

Characteristics of Helicobacter pylori antibiotic resistance: data from four different populations

Dong-sheng Liu et al.

ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL (2019)

Article Gastroenterology & Hepatology

Houston Consensus Conference on Testing for Helicobacter pylori Infection in the United States

Hashem B. El-Serag et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2018)

Article Gastroenterology & Hepatology

Fifth Chinese National Consensus Report on the management of Helicobacter pylori infection

Wen Zhong Liu et al.

HELICOBACTER (2018)

Article Gastroenterology & Hepatology

Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report

P. Malfertheiner et al.

Review Gastroenterology & Hepatology

Primary Antibiotic Resistance of Helicobacter pylori in China

Yi Hu et al.

DIGESTIVE DISEASES AND SCIENCES (2017)

Article Gastroenterology & Hepatology

The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults

Carlo A. Fallone et al.

GASTROENTEROLOGY (2016)

Article Gastroenterology & Hepatology

Kyoto global consensus report on Helicobacter pylori gastritis

Kentaro Sugano et al.

Review Infectious Diseases

Systematic review and meta-analysis: susceptibility-guided versus empirical antibiotic treatment for Helicobacter pylori infection

Sheila Lopez-Gongora et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)

Article Gastroenterology & Hepatology

Rational Helicobacter pylori Therapy: Evidence-Based Medicine Rather Than Medicine-Based Evidence

David Y. Graham et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)

Article Medicine, General & Internal

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

Julian P. T. Higgins et al.

BMJ-BRITISH MEDICAL JOURNAL (2011)

Article Infectious Diseases

Cost analysis and antimicrobial susceptibility testing comparing the E test and the agar dilution method in Campylobaeter jejuni and Campylobacter coli

Alfonso Valdivieso-Garcia et al.

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2009)

Letter Microbiology

Novel mutation in 23S rRNA that confers low-level resistance to clarithromycin in Helicobacter pylori

Emiko Rimbara et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)